Status:

COMPLETED

Open-label Study of ASP2151 in Herpes Simplex Patients

Lead Sponsor:

Maruho Co., Ltd.

Conditions:

Herpes Simplex

Eligibility:

All Genders

16-79 years

Phase:

PHASE3

Brief Summary

A multicenter, open-label study is conducted to evaluate the efficacy and safety of ASP2151 in patients with herpes simplex (recurrent labial/facial herpes and recurrent genital herpes and Kaposi vari...

Eligibility Criteria

Inclusion

  • Patients with a rash associated with herpes simplex and a recurrent episode meeting the following criteria
  • Recurrent labial/facial herpes: Patients with at least 10 papulae or vesicles/pustules
  • Recurrent genital herpes: Patients with at least 5 papules or vesicles/pustules on the genital organs or in the genital and circumanal region
  • Kaposi varicelliform eruption: Patients with major skin symptoms of papulae or vesicles
  • Patients who can start receiving the study drug within 48 hours after onset of rash
  • Age: 16 years or older, but younger than 80 years

Exclusion

  • Patients who are not expected to have an adequate response to oral antiviral medication.
  • Patients with two or more types of herpes simplex.
  • An extreme decline in immune function
  • Presence of serious complications
  • Patients found to meet any of the following conditions based on laboratory tests performed within 14 days before informed consent:
  • AST or ALT ≥ 2.5 x upper limit of normal
  • Platelet count \< lower limit of normal
  • Serum creatinine ≥ 1.5 mg/dL
  • Creatinine clearance \< 30 mL/min
  • Current or previous history of malignant tumor within 5 years before informed consent
  • Diagnosis of autoimmune disease

Key Trial Info

Start Date :

November 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 20 2015

Estimated Enrollment :

275 Patients enrolled

Trial Details

Trial ID

NCT02209324

Start Date

November 1 2013

End Date

August 20 2015

Last Update

September 27 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Sapporo Hokkaido Japan

Sapporo, Japan

2

Oota-ku Tokyo Japan

Tokyo, Japan

3

Yokohama Kanagawa Japan

Yokohama, Japan